CASTELLI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 175
NA - Nord America 158
AS - Asia 23
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 359
Nazione #
US - Stati Uniti d'America 158
SE - Svezia 107
IT - Italia 48
CN - Cina 18
FI - Finlandia 8
DE - Germania 6
IE - Irlanda 3
SG - Singapore 3
IN - India 2
RO - Romania 2
AU - Australia 1
EU - Europa 1
FR - Francia 1
ZA - Sudafrica 1
Totale 359
Città #
Ashburn 45
Milan 39
Princeton 24
Lawrence 23
Shanghai 16
New York 10
Helsinki 8
Los Angeles 4
Bologna 3
Dublin 3
Frankfurt Am Main 3
Ancona 2
Como 2
Pune 2
Bloemfontein 1
Borås 1
Guangzhou 1
Lansing 1
Melbourne 1
Riverside 1
Rockville 1
Rome 1
Seattle 1
Segrate 1
Totale 194
Nome #
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 35
A Biologically-validated HCV E1E2 Heterodimer Structural Model 23
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 21
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 19
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 19
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 19
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 19
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 18
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 17
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 17
Viral Respiratory Pathogens and Lung Injury 17
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 16
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 15
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 15
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 14
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 13
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 13
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets 13
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 13
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 12
HCV E2 core structures and mAbs: something is still missing 12
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 12
Role and potential therapeutic use of antibodies against herpetic infections 12
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 9
Salts drive controllable multilayered upright assembly of amyloid-like peptides at mica/water interface 9
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 7
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 3
null 1
Totale 413
Categoria #
all - tutte 4.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 5 0 0 0 0 0 1 0 0 0 0 1
2020/20219 2 0 0 1 0 0 1 0 0 5 0 0
2021/202230 2 1 7 4 0 0 0 2 2 3 3 6
2022/2023186 57 45 25 1 1 27 10 11 7 0 2 0
2023/2024149 0 9 26 30 14 33 4 20 4 9 0 0
Totale 413